Centrica gains more than 1% and outperforms the trend in London, helped by UBS, which raises its recommendation on the British energy group's shares from 'neutral' to 'buy', with an adjusted target price of 165 to 170 pence.

'We believe that the targets for Centrica Energy are not demanding. A new nuclear build could be strategically and commercially justified in a RAB (regulated asset base) structure", the broker believes.

Copyright (c) 2024 CercleFinance.com. All rights reserved.